FibroGen Inc. $(FGEN)$ has announced a 1-for-25 reverse stock split, effective June 16, 2025. The company's common stock will begin trading on a split-adjusted basis on June 17, 2025, under the existing trading symbol "FGEN." This move aims to increase the per-share market price to meet Nasdaq's minimum bid price requirement and reduce the number of outstanding shares from approximately 101.1 million to around 4.0 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.